Literature DB >> 8390406

Mechanism of protective immunity induced by porin-lipopolysaccharide against murine salmonellosis.

S Muthukkumar1, V R Muthukkaruppan.   

Abstract

Investigations were undertaken to characterize the protective immunity induced by porin-lipopolysaccharide (LPS) against Salmonella typhimurium infection in mice. Mice immunized with porin-LPS showed higher levels of antiporin immunoglobulin G than mice which received porin alone. Further, T cells from porin-LPS-immunized mice showed an augmented proliferative response to porin in vitro compared with the response of T cells from porin-injected animals. The passive transfer of anti-LPS antibodies conferred significant protection (17%), while antiporin serum failed to protect mice against lethal challenge, indicating the protective ability of anti-LPS antibodies. However, the transfer of serum obtained from porin-LPS-immunized mice resulted in better protection (30%) than did anti-LPS or antiporin antibodies alone. In contrast to LPS, monophosphoryl lipid A completely failed to induce protection against lethal infection. However, comparable to the effect of LPS, injection of porin with monophosphoryl lipid A enhanced antibody response and the protective ability of porin (81.25%). The transfer of T cells from porin-LPS-immunized mice provided higher levels of protection (47%) against lethal challenge than did T cells from porin-immunized mice (23%). The combination of T cells and serum from porin-immunized mice transferred 36% protection. However, a combination of T cells and serum from porin-LPS-immunized mice conferred the highest level of protection (92%), which was reflected by the number of survivors (100%) in the porin-LPS-immunized group. These results demonstrate that besides the protective effect of anti-LPS antibodies, the ability of LPS to augment humoral and cell-mediated immune responses to porin confers effective protection against Salmonella infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390406      PMCID: PMC280954          DOI: 10.1128/iai.61.7.3017-3025.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  T cell requirements for the expression of the lipopolysaccharide adjuvant effect in vivo: evidence for a T cell-dependent and a T cell-independent mode of action.

Authors:  D B Ness; S Smith; J A Talcott; F C Grumet
Journal:  Eur J Immunol       Date:  1976-09       Impact factor: 5.532

2.  LPS and specific T cell responses: interleukin 1 (IL 1)-independent amplification of antigen-specific T helper (TH) cell proliferation.

Authors:  G Bismuth; M Duphot; J Theze
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

3.  Characterization of porins from the outer membrane of Salmonella typhimurium. 2. Physical properties of the functional oligomeric aggregates.

Authors:  M Tokunaga; H Tokunaga; Y Okajima; T Nakae
Journal:  Eur J Biochem       Date:  1979-04

4.  Importance of thymus-derived lymphocytes in cell-mediated immunity to infection.

Authors:  R J North
Journal:  Cell Immunol       Date:  1973-04       Impact factor: 4.868

5.  Proteins from Salmonella R-mutants mediating protection against Salmonella typhimurium infection in mice I. Preparation of proteins free from lipopolysaccharide using various chromatographic methods.

Authors:  N Bhatnagar; W Müller; S Schlecht
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1982-10

6.  Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation.

Authors:  A C Allison; A J Davies
Journal:  Nature       Date:  1971-10-01       Impact factor: 49.962

7.  Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes.

Authors:  J W Killion; D C Morrison
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

8.  Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice.

Authors:  S B Svenson; A A Lindberg
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

9.  The protective capacity of immune sera in experimental mouse salmonellosis is mainly due to IgM antibodies.

Authors:  H Saxen; O Mäkelä
Journal:  Immunol Lett       Date:  1982-11       Impact factor: 3.685

10.  Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.

Authors:  D E Colwell; S M Michalek; D E Briles; E Jirillo; J R McGhee
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

View more
  14 in total

Review 1.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

2.  Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties.

Authors:  Mario A Moreno-Eutimio; Alejandra Tenorio-Calvo; Rodolfo Pastelin-Palacios; Christian Perez-Shibayama; Cristina Gil-Cruz; Rubén López-Santiago; Isabel Baeza; Marcos Fernández-Mora; Laura Bonifaz; Armando Isibasi; Edmundo Calva; Constantino López-Macías
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

3.  Protection mediated by antibodies to iron-regulated outer-membrane proteins of S. typhi in a mouse peritonitis model.

Authors:  Shaloo Sood; Praveen Rishi; Veena Dhawan; Saroj Sharma; Nirmal Kumar Ganguly
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

4.  Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response.

Authors:  Ismael Secundino; Constantino López-Macías; Luisa Cervantes-Barragán; Cristina Gil-Cruz; Nora Ríos-Sarabia; Rodolfo Pastelin-Palacios; Miguel Angel Villasis-Keever; Ingeborg Becker; José Luis Puente; Edmundo Calva; Armando Isibasi
Journal:  Immunology       Date:  2006-01       Impact factor: 7.397

5.  Salmonella enterica serovar Typhimurium ompS1 and ompS2 mutants are attenuated for virulence in mice.

Authors:  Olivia Rodríguez-Morales; Marcos Fernández-Mora; Ismael Hernández-Lucas; Alejandra Vázquez; José Luis Puente; Edmundo Calva
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  Negative osmoregulation of the Salmonella ompS1 porin gene independently of OmpR in an hns background.

Authors:  Mario Alberto Flores-Valdez; José Luis Puente; Edmundo Calva
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

7.  Antigenic determinants of the OmpC porin from Salmonella typhimurium.

Authors:  S P Singh; S R Singh; Y U Williams; L Jones; T Abdullah
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  OmpR and LeuO positively regulate the Salmonella enterica serovar Typhi ompS2 porin gene.

Authors:  Marcos Fernández-Mora; José Luis Puente; Edmundo Calva
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

9.  Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits.

Authors:  Steven B Yee; David N Dyer; Nancy A Twenhafel; M Louise M Pitt
Journal:  Comp Med       Date:  2013-06       Impact factor: 0.982

10.  Binding of Legionella pneumophila to macrophages increases cellular cytokine mRNA.

Authors:  Y Yamamoto; S Okubo; T W Klein; K Onozaki; T Saito; H Friedman
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.